Skip to main content
Blueprint Medicines Corporation (LON:0HOJ)
London flag London · Delayed Price · Currency is GBP · Price in USD
103.51
+1.14 (1.11%)
At close: May 5, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Collaboration and License
-
Log In
Log In
Log In
Log In
Collaboration and License Growth
-
Log In
Log In
Log In
Log In
AYVAKIT/AYVAKYT
535.84M
Log In
Log In
Log In
Log In
AYVAKIT/AYVAKYT Growth
107.96%
Log In
Log In
Log In
Log In
GAVRETO
-
Log In
Log In
Log In
Log In
GAVRETO Growth
-
Log In
Log In
Log In
Log In
Total Product
535.84M
Log In
Log In
Log In
Log In
Total Product Growth
107.96%
Log In
Log In
Log In
Log In
License Revenue - Related Party
-
Log In
Log In
Log In
Log In